Hims & Hers Health, Inc. (HIMS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Core Insights - Wall Street anticipates a year-over-year increase in earnings for Hims & Hers Health, Inc. (HIMS) driven by higher revenues, with a consensus EPS estimate of $0.09, reflecting a 50% increase from the previous year, and revenues expected to reach $583.68 million, up 45.4% year-over-year [1][3] Earnings Expectations - The upcoming earnings report is scheduled for November 3, and the stock may rise if actual results exceed expectations, while a miss could lead to a decline [2] - The consensus EPS estimate has been revised down by 3.96% over the last 30 days, indicating a reassessment by analysts [4] Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that the Most Accurate Estimate for Hims & Hers is lower than the consensus, resulting in an Earnings ESP of -12.79%, suggesting a bearish outlook from analysts [12] - The stock currently holds a Zacks Rank of 3, complicating predictions of an earnings beat [12] Historical Performance - In the last reported quarter, Hims & Hers was expected to post earnings of $0.18 per share but delivered $0.17, resulting in a surprise of -5.56% [13] - Over the past four quarters, the company has only beaten consensus EPS estimates once [14] Industry Comparison - Another player in the Zacks Medical Info Systems industry, Omnicell (OMCL), is expected to report earnings of $0.36 per share, reflecting a year-over-year decrease of 35.7%, with revenues projected at $294.06 million, up 4.1% [18] - Omnicell's consensus EPS estimate has been revised up by 8.2% in the last 30 days, but it also has a negative Earnings ESP of -13.89%, making predictions of an earnings beat challenging [19][20]